Generic Name and Formulations:
Metronidazole 0.75%; vaginal gel; contains parabens.
Upsher-Smith Laboratories, Inc.
Indications for VANDAZOLE:
One applicatorful once daily at bedtime, or twice daily, for 5 days.
Pre-menarchal: not recommended.
Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Do not have vaginal intercourse or use tampons or douches during therapy. Pregnancy (Cat.B). Nursing mothers: not recommended.
Avoid concomitant alcohol. Do not give within 2 weeks of disulfiram (possible psychotic reactions). May potentiate oral anticoagulants, lithium. May be potentiated by cimetidine. May interfere with serum chemistry tests.
Fungal infection, headache, pruritus, abdominal pain, GI upset, dysmenorrhea, pharyngitis.
Gel—70g (w. applicators)
Neurology Advisor Articles
- The Consequences of Compensation in Autism
- Fingolimod May Help Prevent Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis
- Novel Therapy May Improve Symptoms in Early Huntington Disease
- Interaction of Alcohol, Smoking on Multiple Sclerosis Severity
- Demoralization Common in Patients With Parkinson Disease
- Multiple Sclerosis Guidelines: AAN's Recommendations for Initiating, Switching, Stopping Disease-Modifying Therapy
- Migraine a Common Comorbidity in Individuals With Sarcoidosis
- Cardiovascular Risk Factors and Development of Brain Atrophy in Multiple Sclerosis
- Association Between Multiple Sclerosis Relapses and Vaccinations
- Understanding Impulse Control Disorders in Parkinson Disease: Developments and Treatments